Workstream Type: Data Analysis
-
Pricing in the Market for Anticancer Drugs
Read More
-
The 340B Program: Hospitals Profit by Reaching Affluent Communities
Read More
-
Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs
Read More
-
Targeted Drugs for Metastatic Renal Cell Carcinoma
Read More